FDA.reportPublic FDA data

Application 200161

Type
ANDA
Sponsor
NATCO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LETROZOLELETROZOLETABLET;ORAL2.5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50268-476LETROZOLELETROZOLEAvPAKANDACurrent
50268-476LETROZOLELETROZOLEAvPAKANDACurrent
51991-759LETROZOLELETROZOLEBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-759LETROZOLELETROZOLEBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-759LETROZOLELETROZOLEBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-759LETROZOLELETROZOLEBreckenridge Pharmaceutical, Inc.ANDACurrent
51991-759LETROZOLELETROZOLEBreckenridge Pharmaceutical, Inc.ANDACurrent
63850-0025LetrozoleLetrozoleNatco Pharma LimitedANDACurrent
71335-1526LETROZOLELETROZOLEBryant Ranch PrepackANDACurrent
71335-1526LETROZOLELETROZOLEBryant Ranch PrepackANDACurrent
71335-1526LETROZOLELETROZOLEBryant Ranch PrepackANDACurrent
71335-1526LETROZOLELETROZOLEBryant Ranch PrepackANDACurrent
71335-1628LETROZOLELETROZOLEBryant Ranch PrepackANDACurrent